Translational study of targeting Dynamin-1 and podocyte actin cytoskeleton to reduce proteinuria in chronic kidney disease
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Natasha Kangololo und 3 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, NO. 24 TongJia…. Hauptthemen laut MEDLINE: Podocytes, Renal Insufficiency, Chronic, Proteinuria, Actin Cytoskeleton. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Essential for podocyte function in the kidneys, Dynamin-1 (Dyn-1) is a protein composed of four domains. GTP binding and hydrolysis, necessary for membrane fission during clathrin-mediated endocytosis, are handled by its GTP hydrolase domain. Dyn-1 polymerizes into helical structures encircling vesicle necks during GTP hydrolysis, thereby facilitating membrane fission and cargo release, crucial for cell signaling and nutrient absorption. In podocytes, Dyn-1 regulates actin dynamics through interactions with actin-binding proteins, maintaining maintenance of actin cytoskeleton and cellular architecture. Dysregulation of Dyn-1 expression is implicated in foot process effacement, proteinuria, and progressive renal failure. Some of the therapeutic strategies that have been shown to enhance Dyn-1 oligomerization have been effective in the restoration of podocyte function in chronic kidney disease (CKD) models. Certain signaling pathways, including PI3K/Akt and TGF-β, are interconnected with actin dynamics, while RhoA interacts with Dyn-1 in modulating actin dynamics. Compounds such as Bis-T-23 promote Dyn-1 oligomerization and actin filament polymerization, restoring pathological podocyte structural alterations. A comprehensive understanding of Dyn-1's complex roles in podocyte structure and maintenance is needed; this is crucial for developing new strategies to protect these cells, preserve renal function, and improve the quality of life in CKD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, NO. 24 TongJiaXiang St., Nanjing, Jiangsu, 210009, China.
- Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, NO. 155 HanZhong Rd., Nanjing, Jiangsu, 210009, China.
- Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, NO. 155 HanZhong Rd., Nanjing, Jiangsu, 210009, China. Electronic address: yfy158@njucm.edu.cn.
- New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, NO. 24 TongJiaXiang St., Nanjing, Jiangsu, 210009, China. Electronic address: brookm…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Kangololo, N., Sheng, P., An, X., & Yan, M. (2025). Translational study of targeting Dynamin-1 and podocyte actin cytoskeleton to reduce proteinuria in chronic kidney disease. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178237
Vancouver
Kangololo N, Sheng P, An X, Yan M. Translational study of targeting Dynamin-1 and podocyte actin cytoskeleton to reduce proteinuria in chronic kidney disease. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178237
BibTeX
@article{Kangololo2025,
author = {Kangololo, Natasha and Sheng, Pei and An, Xiaofei and Yan, Ming},
title = {Translational study of targeting Dynamin-1 and podocyte actin cytoskeleton to reduce proteinuria in chronic kidney disease},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178237}
}
EUVIMED